Key result
Clinically severe RyR2 mutations alter interdomain interactions and cause abnormal Ca2+ release after channel activation, exhibiting threshold characteristics (caffeine >2.5 mmol/L; Ca2+ >150 nmol/L).
SCD-linked RyR2 mutations cause abnormal Ca2+ release through altered interdomain interactions and conformational instability following channel activation.
May flag Ca2+ thresholds for arrhythmia risk in RyR2 carriers; leaves open in vivo validation and targeted therapies.
Arrhythmogenic cardiac ryanodine receptor (RyR2) mutations are associated with stress-induced malignant tachycardia, frequently leading to sudden cardiac death (SCD). The causative mechanisms of RyR2 Ca2+ release dysregulation are complex and remain controversial. We investigated the functional impact of clinically-severe RyR2 mutations occurring in the central domain, and the C-terminal I domain, a key locus of RyR2 autoregulation, on interdomain interactions and Ca2+ release in living cells. Using high-resolution confocal microscopy and fluorescence resonance energy transfer (FRET) analysis of interaction between fusion proteins corresponding to amino- (N-) and carboxyl- (C-) terminal RyR2 domains, we determined that in resting cells, RyR2 interdomain interaction remained unaltered after introduction of SCD-linked mutations and normal Ca2+ regulation was maintained. In contrast, after channel activation, the abnormal Ca2+ release via mutant RyR2 was intrinsically linked to altered interdomain interaction that was equivalent with all mutations and exhibited threshold characteristics (caffeine >2.5 mmol/L; Ca2+ >150 nmol/L). Noise analysis revealed that I domain mutations introduced a distinct pattern of conformational instability in Ca2+ handling and interdomain interaction after channel activation that was absent in signals obtained from the central domain mutation. I domain-linked channel instability also occurred in intact RyR2 expressed in CHO cells and in HL-1 cardiomyocytes. These new insights highlight a critical role for mutation-linked defects in channel autoregulation, and may contribute to a molecular explanation for the augmented Ca2+ release following RyR2 channel activation. Our findings also suggest that the mutational locus may be an important mechanistic determinant of Ca2+ release channel dysfunction in arrhythmia and SCD.
No takes yet. Share an insight, caveat, or question.
George et al. (2005) studied Arrhythmogenic cardiac ryanodine receptor (RyR2) mutations. RyR2 mutations (central domain and C-terminal I domain) vs. Wild-type/normal RyR2 was evaluated on Interdomain interactions and Ca2+ release. Clinically severe RyR2 mutations alter interdomain interactions and cause abnormal Ca2+ release after channel activation, exhibiting threshold characteristics (caffeine >2.5 mmol/L; Ca2+ >150 nmol/L).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: